Clinical Trial Update: Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)

View source ↗

Summary

A clinical trial (P08166) sponsored by Merck Sharp & Dohme LLC for Crohn's disease and ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Status: WITHDRAWN